Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Small Pharma Inc V.DMT

Small Pharma Inc. is a biotechnology company focused on short-duration psychedelic therapies for mental health conditions. The Company is focused on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions that are scalable, commercially differentiated, and conveniently dosed, with the goal of addressing key unmet needs in the treatment of... see more

Recent & Breaking News (TSXV:DMT)

Small Pharma Announces Engagement of Investor Relations Provider

GlobeNewswire September 15, 2021

Small Pharma to Present at Upcoming September Investor Conferences

GlobeNewswire September 10, 2021

Small Pharma to Headline the 2021 DMT Conference: A Molecular Masterclass

GlobeNewswire September 8, 2021

Small Pharma Announces Appointment of Lyne Fortin as Chair of the Board

GlobeNewswire August 27, 2021

CORRECTION FROM SOURCE: BTV Examines the Rapidly Expanding Psychedelics Market

Newsfile August 17, 2021

BTV Examines the Rapidly Expanding Psychedelics Market

Newsfile August 17, 2021

Small Pharma To Present At Canaccord Genuity's Annual Growth Conference

PR Newswire August 9, 2021

Small Pharma Reports First Fiscal Quarter 2021 Highlights

GlobeNewswire July 30, 2021

Small Pharma Establishes Psychedelic-assisted Therapy Training Program

PR Newswire July 21, 2021

Small Pharma To Present Progress And Innovations In DMT-Assisted Therapy For The Treatment Of Depression At Upcoming Conferences

Canada NewsWire June 25, 2021

Small Pharma Engages LifeSci Advisors as Investor Relations Agency

GlobeNewswire June 22, 2021

Small Pharma Inc. Expands Phase I/IIa Clinical Trial With Additional Study Site

PR Newswire June 1, 2021

Small Pharma Virtually Opens The Market

Canada NewsWire May 14, 2021

Small Pharma Engages Market-Maker

GlobeNewswire May 7, 2021

Small Pharma Provides Update to Patent Portfolio Including Receipt of an in Order for Grant Notice for its Patent Related to Psychedelic Tryptamines

GlobeNewswire May 7, 2021